52.98
+1.36
+(2.63%)
As of 8:09:03 AM GMT+1. Market open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating cash flow
-211,644.00
-145,367.00
-92,517.00
-79,681.00
-70,804.00
Investing cash flow
-112,194.00
-223,623.00
-63,825.00
42,280.00
-9,761.00
Financing cash flow
370,357.00
353,316.00
255,632.00
602.00
203,107.00
End cash position
316,065.00
234,207.00
249,881.00
150,591.00
187,390.00
Interest paid supplemental data
3,716.00
2,483.00
441.00
--
--
Capital expenditure
--
--
--
--
-148.00
Issuance of capital stock
355,443.00
335,429.00
241,200.00
--
202,554.00
Issuance of debt
10,000.00
15,000.00
10,000.00
--
--
Free cash flow
-212,643.00
-145,367.00
-92,517.00
-79,681.00
-70,952.00
12/31/2020 - 8/13/2019
Upgrade to start utilising 40 years of financial statements and gain so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets and cash flows - all exportable.
UpgradeRelated tickers
PI3.SG Gubra AS
88.60
+1.37%
ISI.MU Ionis Pharmaceuticals Inc
31.99
+0.28%
42Z.F Revolution Medicines, Inc.
41.40
+6.15%
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.49%
YDO1.F Madrigal Pharmaceuticals, Inc.
322.80
-0.06%
2H51.BE Ocugen Inc
0.7285
+4.00%
VRTX.MX Vertex Pharmaceuticals Incorporated
9,101.43
+0.27%
INNMF Amplia Therapeutics Limited
0.0450
0.00%
VLA.VI Valneva SE
2.3940
+2.84%
37Z.BE Allakos Inc
0.1969
-2.62%